The maximum sharing limit of a single project is 10 million yuan!"Implementation Rules for the Management of R & D Risk Sharing Fund in Sichuan Province"
Author:Cover news Time:2022.07.02
Cover Journalist Zeng Ya
On July 2, the cover reporter learned from the Sichuan Provincial Administration of Traditional Chinese Medicine that in order to further inspire and protect the enthusiasm, initiative and creativity of Chinese medicine technology innovation enterprises in the province, reduce the risk The construction of the reform demonstration zone and the strong province of traditional Chinese medicine. Recently, the Sichuan Provincial Administration of Traditional Chinese Medicine and the Sichuan Provincial Department of Finance jointly issued the notice of the "Implementation Rules for the Implementation of the Management of the R & D Risk Sharing Fund in Sichuan Province".
The "Sichuan Provincial Traditional Chinese Medicine R & D Risk sharing fund" (hereinafter referred to as the risk -sharing fund) is used to share the loss of risk losses in the investment and innovation input of Chinese medicine. It is mainly for enterprises that develop Chinese medicine scientific and technological innovation, accept applications for risk sharing of enterprises, and implement normalized acceptance and regular review systems. Applicable objects include the establishment, registration, and registration in the administrative area of Sichuan Province. Chinese medicine planting (breeding), production, processing, research and development such as independent legal person qualifications.
The full text is as follows:
Implementation rules for the management of R & D risk sharing fund in Sichuan Province
Chapter 1 General Principles
Article 1 In order to further inspire and protect the enthusiasm, initiative and creativity of Chinese medicine scientific and technological innovation enterprises in the province, reduce the risk of scientific research in Chinese medicine in enterprises, and promote the high -quality development of the Chinese medicine industry in our province. According to national laws and regulations, and the "Implementation Opinions of the Sichuan Provincial Party Committee of the Sichuan Provincial Party Committee of the Communist Party of China on Promoting the Innovation and Development of TCM inheritance" (Sichuan Committee [2020] No. 7) and "Sichuan Provincial Traditional Chinese Medicine R & D Risk Establishment Fund Establishment Plan" (Sichuan Traditional Chinese Medicine Office [2020] No. 2) and other documents, and the Sichuan Provincial Administration of Traditional Chinese Medicine and the Sichuan Provincial Department of Finance jointly formulated this implementation rules.
Article 2 The "Sichuan Provincial Traditional Chinese Medicine R & D Risks sharing fund" (hereinafter referred to as the risk -sharing fund) referred to the implementation rules of these implementation is used to share the loss of risk losses in the research and development innovation investment of Chinese medicine. Provincial finances arrange fund injection -sharing funds in the development of traditional Chinese medicine development funds, and arrange supplements in a timely manner according to the actual use of the insurance fund.
Article 3 The use and management of dangerous funds strictly abide by the relevant laws, regulations, and rules and regulations of the state and Sichuan Province, and follow the principles of honest application, impartial review, scientific management, and openness and transparency.
Article 4 Restriction funds to enterprises that open up Chinese medicine scientific and technological innovation, accept applications for risk sharing of enterprises, and implement normalized acceptance and regular evaluation systems.
Article 5 The insurance fund shall be responsible for specific organizations and implementation by the Provincial Administration of Traditional Chinese Medicine to fulfill the relevant management functions.
Chapter 2 Applicable objects and conditions
Article 6 The applicable objects of dangerous funds include the establishment, registration, and registration in the administrative area of Sichuan Province. Chinese medicine planting (breeding), production, processing, research and development such as independent legal person qualifications, and related companies with independent legal persons.
Article 7 The applicable object of the danger fund shall meet the following conditions:
(1) Operating in accordance with the law and paying taxes according to the rules, the person in charge of the unit and the project has not been included in the list of dishonesty behaviors by the relevant functional departments, and has not occurred in the past 5 years.
(2) With a sound financial management system and institution;
(3) Talent teams with strong research and development capabilities, have necessary R & D, experiments, services and other conditions;
(4) Promise research and development results preferentially transformed in the administrative area of Sichuan;
(5) After the failure of the same project, it is not allowed to obtain compensation for this insurance fund.
Chapter III Division Scope and Standards
Article 8 The scope of risk sharing includes Chinese medicine innovative drugs, new Chinese medicine improved new drugs, ancient classic famous Chinese medicine compound preparations, same names of the same name, traditional Chinese medicine medical device, traditional Chinese medicine health food and Chinese medicine veterinary medicine, secondary development of Chinese medicine after the listing Research, development and technological innovation, technical application, and technological achievements of traditional Chinese medicine drinks.
Article 9 of the sharing standard:
(1) For the failure of the uncertainty in the process of major national policy, the uncertainty in the scientific research process, and the failure of other irresistible research and development projects, the fund is given a risk of 30%of the loss of 30%of the loss of 30%of the losses of 30%of the loss of actual scientific research (hereinafter referred to as actual investment). Sharing;
(2) The actual investment of the project shared by the danger fund sharing does not include financial subsidy funds. The actual investment computing shall be from the date of submitting relevant filing materials to the Provincial Traditional Chinese Medicine Bureau to the date of the report of the report issued by the accounting firm; the actual investment of a single project shall not be less than 1 million yuan;
(3) The relevant costs of house land are not included in actual investment; in fixed assets, the depreciation of only dedicated equipment is incorporated into actual investment. The labor expense expenses of scientific researchers who have invested in actual input should not exceed 20%of the total investment funds.
Article 10 Setting Settings Settings Settings Settings Settings:
(1) The category of Chinese medicine raw materials, the maximum score limit of a single project is 1 million yuan;
(2) Chinese medicine drinks, second -class traditional Chinese medicine medical equipment, traditional Chinese medicine health food, Chinese medicine veterinary drug, etc., the maximum sharing limit of a single project is 3 million yuan;
(3) New drugs of traditional Chinese medicine, Chinese medicine compound preparations of ancient classic prescriptions, the same name of the same name, secondary development of Chinese medicine after the listing, three types of traditional Chinese medicine medical equipment, etc., the maximum sharing limit of a single project is 5 million yuan;
(4) The category of Chinese medicine innovation medicines, the maximum score limit for a single project is 10 million yuan.
Article 11 For project research and development failure caused by unreasonable factors such as incomplete scientific research progress and insufficient investment in scientific research funds after the project is started, and insurance funds will not share losses. Chapter 4 Project Record
Article 12 The fund filing materials submitted by the application unit include the following content:
(1) "Application Form for the Recruitment Fund of R & D Risk Substance of TCM in Sichuan Province" (Annex 1);
(2) Copy of business licenses in the enterprise;
(3) The credit report of the company last year;
(4) There have been no major security, environmental protection, and quality accidents in the past 5 years;
(5) Project goals that can be clear and appraisal;
(6) A commitment to the development of research and development results in the administrative area of Sichuan;
(7) qualification materials for the conditions such as research and development, testing, and service;
(8) Relevant financial certification materials for enterprise operations.
Article 13 The undertaking unit of the R & D project of the risk sharing shall be submitted to the Provincial Administration of Traditional Chinese Medicine and submitted to the provincial Traditional Chinese Medicine Bureau and submitted to the filing materials. Register and numbers the projects that meet the requirements of risk sharing. From the date of submitting relevant filing materials to the Provincial Traditional Chinese Medicine Bureau, the implementation progress and capital investment of enterprise scientific research projects are included in the management of the project filing library.
Chapter 5 Record Management
Article 14 The project leader of the project shall conscientiously formulate the implementation plan of the project organization, clarify the specific implementation plan and time progress of various research tasks, and provide condition guarantee and support for the completion of the project task goals. For project funds separately, special funds are dedicated, and under the supervision and inspection of relevant departments.
Article 15 The mid -term inspection of the project. For projects with a record period of 2 years or more, during the implementation of the project, the third -party institution entrusted by the Provincial Traditional Chinese Medicine Bureau or the Provincial Administration of Traditional Chinese Medicine will conduct a mid -term inspection of the project implementation. The mid -term inspection can be used as the basis for the project filing, registered adjustment, and record termination.
Article 16 During the filing of the project, if the project has made significant progress, breakthroughs, or major issues that occur, or important issues that need to be coordinated, the project undertaking unit must report to the Provincial Bureau of Traditional Chinese Medicine in a timely manner.
Article 17 The change (adjustment) of project matters. During the implementation of the project, before the project filing time expires (the extension of the project in the filing of the project is delayed according to the approval time), the following matters can be made (adjustment) for changes (adjustment), and the approval is approved in accordance with the procedure.
(1) Due to the change in the equity of the undertaking unit, the industry and commerce renovation, the internal business adjustment of the group, the project bearing unit is required. The application for a written application before and after the change of the undertaking unit will be reported to the Provincial Traditional Chinese Medicine Bureau for review and the change;
(2) The person in charge of the project cannot host the research work of the project due to work mobilization, settlement of abroad, major illness, and death. If the person in charge of the project is required without affecting the implementation of the project, the project responsible unit shall submit a written application, and the project undertaking unit shall apply for a written application. Report to the Provincial Administration of Traditional Chinese Medicine for review and change;
(3) Change major adjustments such as the main research and development personnel, the main research goals and assessment indicators, etc., and the project undertaking unit submits a written application and reports to the Provincial Traditional Chinese Medicine Bureau for approval.
Article 18 The record is terminated. If one of the following situations is encountered during the implementation of the project, the Provincial Administration of Traditional Chinese Medicine has the right to terminate the project's filing.
(1) Undertaking unit failure, bankruptcy or long -term loss, etc.;
(2) The record time is overdue;
(3) Through the mid -term inspection, performance evaluation, supervision and inspection, report reflection, etc., it is found that the project undertaking unit or the project leader of the project will falsify and plagiarize the scientific and technological achievements of others during the project implementation process. There are problems such as major violations of discipline and disciplinary use, and do not rectify or refuse to rectify in accordance with regulations.
Article 19 If the project shall not be completed on time to apply for a period of time, the project undertaking unit shall submit an extension application before the project filing time expires, and it shall be submitted to the Provincial Administration of Traditional Chinese Medicine for approval. Project filing extension can generally only apply once, and the extension time generally does not exceed 1 year. In special circumstances, the application for filing is submitted again.
Article 20 The project filing time principle does not exceed 5 years.
Chapter 6 Fund Application and Review
Article 21 Fund application materials submitted by the application unit include the following content:
(1) "Application Form for Sichuan Provincial Traditional Chinese Medicine R & D Risk Elberry Fund" (Annex 3);
(2) Proof of project failure;
(3) Analysis report of project failure;
(4) Special audit report issued by the third -party accounting firms investing in project funding is invested. The audit period is from the date of submitting relevant filing materials to the Provincial Traditional Chinese Medicine Bureau from the project unit to the date of the report of the report on the accounting firm;
(5) Whether to obtain other fiscal subsidies.
Article 22 If the risk loss occurs in the project, the project application unit shall submit an application for risk sharing; before submitting the application for risk sharing, the project application unit must make a explanation of whether the project has obtained other financial subsidies and publicize it. The Provincial Administration of Traditional Chinese Medicine, together with departments such as the Finance Department, organizes relevant experts to review the project. If necessary, you can entrust professional institutions or qualified social intermediaries to conduct review; the results of the review will be publicized by the Provincial Traditional Chinese Medicine Bureau and the Finance Department. If there is no objection after the publicity period expires, the risk sharing subsidy is given according to the procedure.
Chapter 7 Supervision and Security
Article 23 The management and distribution of danger funds shall be supervised by the audit department and the disciplinary inspection department. Once the acts such as crowded, misappropriation, occupation, and corruption funds are verified, they will be dealt with seriously in accordance with regulations, discipline, and law. Article 24 The explanation of whether there is any other financial subsidies for the application project. If there is an unrealistic thing, the danger fund will not shame the risk and incorporate it into the company's blacklist If the fund is subsidized, it will be recovered according to the original channel.
Article 25. For enterprises that provide false materials and fraud and apply funds, the fund is prohibited for life, and the fund has been allowed to be recovered in accordance with the original channels. The regulations are dealt with seriously; if a crime is constituted, it is transferred to the judicial organs to investigate its criminal responsibility.
Chapter 8 Attachment
Article 26 The implementation rules of these implementation shall be explained by the Provincial Traditional Chinese Medicine Bureau and the Finance Department. The implementation rules of these implementation are not exhausted, and it is implemented in accordance with relevant laws, regulations, rules, and standardized documents.
Article 27 The implementation rules of these implementation will be implemented from the date of release.
- END -
Walking in front of the new bureau | Yantai shaped a new advantage of modern industries, and took the lead in the "top ten industries".
The development of Yantai manufacturing is an epic of unremitting innovation.After...
Jiangsu promoted medical insurance to support the development of traditional Chinese medicine inheritance, and "Internet+" Chinese medicine services were included in medical insurance
Content source: China Traditional Chinese Medicine Reporter: Xu JingA few days ago, the Jiangsu Provincial Medical Security Bureau and the Provincial Administration of Traditional Chinese Medicine iss